Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image. The global ED Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the ED Treatment market based on company, product type, end user and key regions. This report studies the global market size of ED Treatment in key regions like North America, Europe, China and Japan, focuses on the consumption of ED Treatment in these regions. This research report categorizes the global ED Treatment market by top players/brands, region, type and end user. This report also studies the global ED Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Eli Lilly Pfizer Bayer BaiYunShan General Factory S.K. Chemicals Teva Pharma Dong-A ST Metuchen Pharma Seoul Pharma CSBIO. ED Treatment market size by Type Sildenafil Tadalafil Others ED Treatment market size by Applications Hospitals Drugstores Other Market size by Region North America United States Canada Mexico Europe Germany France UK Italy Russia Asia-Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines Vietnam Central & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa The study objectives of this report are: To study and analyze the global ED Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of ED Treatment market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global ED Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of ED Treatment submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of ED Treatment are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of ED Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 ED Treatment Product Introduction 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global ED Treatment Market Size Growth Rate by Type 1.4.2 Sildenafil 1.4.3 Tadalafil 1.4.4 Others 1.5 Market by Application 1.5.1 Global ED Treatment Market Size Growth Rate by A